Peer-reviewedCC BYDiagnostics (Basel, Switzerland)1 Oct 2026

Prospective External Validation of the HFA-ICOS Baseline Cardiovascular Risk Classification in Women with Breast Cancer Receiving Anthracycline-Containing Therapy in a Central Asian Cohort

Aiganym Amanova¹
Bekbolat Zholdin¹
Saule Balmagambetova²
Iliada Talipova¹
Gulnara Kurmanalina¹
Saule Madinova³
Mira Baspayeva³
Kulparshan Kubenova⁴
Gulmira Sultanbekova¹
Maria Poltavskaya⁵
Zhenisgul Tlegenova¹

5 affiliations

¹Department of Internal Diseases-2, West Kazakhstan Marat Ospanov Medical University, Aktobe 030019, Kazakhstan; (A.A.); (B.Z.); (I.T.); (G.K.); (G.S.)
²Department of Oncology, West Kazakhstan Marat Ospanov Medical University, Aktobe 030019, Kazakhstan
³Chemotherapy Division, University Medical Center, West Kazakhstan Marat Ospanov Medical University, Aktobe 030019, Kazakhstan; (S.M.); (M.B.)
⁴Clinical Laboratory, University Medical Center, West Kazakhstan Marat Ospanov Medical University, Aktobe 030017, Kazakhstan;
⁵Department of Cardiology, Functional and Ultrasound Diagnostics, Sechenov First Moscow State Medical University, Moscow 119991, Russia;

Read full text PDF Cite

Neoadjuvant concurrent or sequential anthracycline-containing chemotherapy and HER2-targeted agents for HER2-positive breast cancer: a randomized phase 2 study (METIS).
Qiufan Zheng, Shusen Wang, Zhiyong Wu +22
Signal transduction and targeted therapy2 Nov 2026Peer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
Prospective validation of an uncertainty-aware machine learning model for secondary progressive multiple sclerosis classification
A. Parakkal Sreenivasan, Y. Noui, I. Erngren +3
medRxiv7 Oct 2026PreprintCC BYFull textNeurologymedRxiv
Metabolic score for visceral fat as a predictor of new-onset cardiovascular disease in patients with metabolic syndrome: a validation study in two prospective cohorts (UK Biobank and CHARLS).
Zhen Tan, Yijun Liu, Lei Liu +5
BMC cardiovascular disorders1 Aug 2026Peer-reviewedCC BYFull textEndocrinology & metabolismEurope PMCPMC
Cardiac magnetic resonance with myocardial strain as a predictor of anthracycline-induced cardiotoxicity in patients with lymphoma: a prospective multimodality study.
Isabela Bispo Santos da Silva Costa, Bruna Morhy Borges Leal Assunção, Cecilia Beatriz Bittencourt Viana Cruz +11
Cardio-oncology (London, England)1 Jul 2026Peer-reviewedCC BY-NC-NDFull textCardiovascular medicineEurope PMCDOAJ
Association of sleep time with all-cause and cardiovascular mortality among individuals with advanced cardiovascular-kidney-metabolic syndrome : A NHANES-based prospective cohort study
Yangyang Xiong, Yue Yin, Jing Wang +3
Medicine23 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeX RIS

BibTeX

@article{amanova2026prospective,
  title = {{Prospective External Validation of the HFA-ICOS Baseline Cardiovascular Risk Classification in Women with Breast Cancer Receiving Anthracycline-Containing Therapy in a Central Asian Cohort}},
  author = {Aiganym Amanova and Bekbolat Zholdin and Saule Balmagambetova and Iliada Talipova and Gulnara Kurmanalina and Saule Madinova and Mira Baspayeva and Kulparshan Kubenova and Gulmira Sultanbekova and Maria Poltavskaya and Zhenisgul Tlegenova},
  journal = {Diagnostics (Basel, Switzerland)},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13703341},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - Prospective External Validation of the HFA-ICOS Baseline Cardiovascular Risk Classification in Women with Breast Cancer Receiving Anthracycline-Containing Therapy in a Central Asian Cohort
AU  - Aiganym Amanova
AU  - Bekbolat Zholdin
AU  - Saule Balmagambetova
AU  - Iliada Talipova
AU  - Gulnara Kurmanalina
AU  - Saule Madinova
AU  - Mira Baspayeva
AU  - Kulparshan Kubenova
AU  - Gulmira Sultanbekova
AU  - Maria Poltavskaya
AU  - Zhenisgul Tlegenova
PY  - 2026
DA  - 2026/10/01
JO  - Diagnostics (Basel, Switzerland)
UR  - https://europepmc.org/article/PMC/PMC13703341
SN  - 2075-4418
ER  -

Related

Cite